Affinity-matured CD72-targeting Nanobody CAR T-cells Enhance Elimination of Antigen-Low B-cell Malignancies. Read more about Affinity-matured CD72-targeting Nanobody CAR T-cells Enhance Elimination of Antigen-Low B-cell Malignancies.
Multi-omic landscape of human gliomas from diagnosis to treatment and recurrence. Read more about Multi-omic landscape of human gliomas from diagnosis to treatment and recurrence.
Deazaguanylation is a nucleobase-protein conjugation required for type IV CBASS immunity. Read more about Deazaguanylation is a nucleobase-protein conjugation required for type IV CBASS immunity.
A scoping study of the whole-cell imaging literature: a foundational corpus, potential for mesoscale data synthesis, and implications for standardization of an emerging field. Read more about A scoping study of the whole-cell imaging literature: a foundational corpus, potential for mesoscale data synthesis, and implications for standardization of an emerging field.
Smoothened inhibition of PKA at cilia transduces Hedgehog signals. Read more about Smoothened inhibition of PKA at cilia transduces Hedgehog signals.
Gut bacterial lactate stimulates lung epithelial mitochondria and exacerbates acute lung injury. Read more about Gut bacterial lactate stimulates lung epithelial mitochondria and exacerbates acute lung injury.
In vivo validation of the palmitoylation cycle as a therapeutic target in NRAS-mutant cancer. Read more about In vivo validation of the palmitoylation cycle as a therapeutic target in NRAS-mutant cancer.
Stochastically Emergent Tumors offer in vivo whole genome interrogation of cancer evolution from non-malignant precursors. Read more about Stochastically Emergent Tumors offer in vivo whole genome interrogation of cancer evolution from non-malignant precursors.
C12ORF57: a novel principal regulator of synaptic AMPA currents and excitatory neuronal homeostasis. Read more about C12ORF57: a novel principal regulator of synaptic AMPA currents and excitatory neuronal homeostasis.
IL-6 underlies microenvironment immunosuppression and resistance to therapy in glioblastoma. Read more about IL-6 underlies microenvironment immunosuppression and resistance to therapy in glioblastoma.
